October Completion? January and February saw a rate of 0.33 patients per site/month versus the past 12-month average of 0.23 and the full trial average at 0.19. If EDT can maintain the current run rate, it could hit the 150-patient mark in October...per Paradigm.
Although arguably this is best case, it's worthy of note.
If .33/month/site, based on 24 or 25 sites that's 8/month overall. March - Sept = 7 months 7X 8 = 56
Coupled with Breakthru Device Designation by the FDA for rapid post Trial processing - we really are finally approaching the end stage!
MM